"Surpass(ing)" an era of basal-bolus insulin therapy: tirzepatide vs insulin lispro tid added-on to poorly controlled basal insulin-treated type 2 diabetes

被引：0
|
作者：
Frias, J. P. [1 ]
Rosenstock, J. [2 ]
Rodbard, H. W. [3 ]
Tofe, S. [4 ]
Sears, E. [5 ]
Huh, R. [5 ]
Lando, L. Fernandez [5 ]
Patel, H. [5 ]
机构：
[1] Velocity Clin Res, Los Angeles, CA USA
[2] Velocity Clin Res Med City, Dallas, TX USA
[3] Endocrine & Metab Consultants, Rockville, MD USA
[4] Univ Hosp Son Espases, Palma De Mallorca, Spain
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [41] Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents - Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
    Rosenstock, Julio
    Scism-Bacon, Jamie
    Ahmann, Andrew J.
    Jiang, Honghua
    Colon, Gildred
    Martin, Sherry
    DIABETES CARE, 2008, 31 (01) : 20 - 25
  • [42] U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes
    Lowery, Jolene Brown
    Donihi, Amy C.
    Korytkowski, Mary T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (06) : 505 - 507
  • [43] Continuous Glucose Monitoring in hospitalized Patients with Type 2 Diabetes during Basal-Bolus Insulin Therapy
    Schaupp, Lukas
    Neubauer, Katharina
    Mader, Julia
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S15 - S15
  • [44] Optimizing Basal-Bolus Therapy in T2D-A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch vs. an Insulin Pen
    Bergenstal, Richard M.
    Peyrot, Mark
    Dreon, Darlene M.
    Aroda, Vanita
    Bailey, Timothy S.
    Brazg, Ronald L.
    Frias, Juan P.
    Johnson, Mary L.
    Klonoff, David C.
    Kruger, Davida F.
    Ramtoola, Shenaz
    Rosenstock, Julio
    Serusclat, Pierre
    Weinstock, Ruth S.
    Naik, Ramachandra G.
    Shearer, David M.
    Zraick, Vivien
    Levy, Brian L.
    DIABETES, 2018, 67
  • [45] Insulin aspart compared to regular insulin and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
    Arslanian, S
    Foster, C
    Wright, NM
    Stender, S
    Hales, P
    Hale, D
    DIABETOLOGIA, 2005, 48 : A327 - A327
  • [46] Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: Prandial premixed (Lispro/ILPS) vs basal/bolus (Glargine/Lispro) therapy
    Ahmann, A. J.
    Rosenstock, J.
    Colon, G.
    Scism-Bacon, J.
    Jiang, H. H.
    Martin, S.
    DIABETOLOGIA, 2007, 50 : S410 - S410
  • [47] Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens
    Vinagre, Irene
    Sanchez-Hernandez, Juan
    Luis Sanchez-Quesada, Jose
    Angel Maria, Miguel
    de Leiva, Alberto
    Peres, Antonio
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (05): : 249 - 253
  • [48] Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Dario Giugliano
    Paolo Chiodini
    Maria Ida Maiorino
    Giuseppe Bellastella
    Katherine Esposito
    Endocrine, 2016, 51 : 417 - 428
  • [49] Comparison of insulin aspart, regular insulin, and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
    Arslanian, S
    Foster, C
    Wright, N
    Stender, S
    Hu, P
    Hale, P
    Hale, D
    DIABETES, 2005, 54 : A517 - A518
  • [50] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
12345